BENYLIN, created in 2011 (United States), from 2466 sister brands and 17477 competing brands. BENYLIN is owned by JOHNSON & JOHNSON, listed on the stock exchange of New York BENYLIN is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
JOHNSON & JOHNSON
(BENYLIN)
over 5 years*
USD 180.79